Banka Bioloo Q2 Results 2026 (FY27): Order Book ₹83.4 Cr
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Top 10 Construction companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Banka Bioloo Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2 FY26-27 Standalone Total Income: ₹1,656 Lakhs, up 24.5% YoY from ₹1,330 Lakhs (Page 9, 4). Standalone BBL Q2 FY26-27:.
From Banka Bioloo Ltd's Q2 FY27 earnings-call transcript · updated 12 Nov 2026.
How did Banka Bioloo's revenue grow in the September 2026 quarter?
- Q2 FY26-27 Standalone Total Income: ₹1,656 Lakhs, up 24.5% YoY from ₹1,330 Lakhs (Page 9, 4)
- Q2 FY26-27 Consolidated Total Income: ₹1,187 Lakhs, down 9.2% YoY (Page 10)
- H1 FY26-27 Standalone Total Income: ₹3,296 Lakhs (up 22.5% YoY) (Page 9, 4)
- H1 FY26-27 Consolidated Total Income: ₹2,252 Lakhs (Page 10)
- Megaliter Contracted Treatment Capacity: 11 MLD (million litres per day) as of Q2 FY26-27 (Page 11)
- Order Book: ₹83.4 Cr unexecuted as of 30 Sep 2026 (Page 8)
2 more points from Banka Bioloo Ltd's call on revenue
Create a free account to keep reading this call
What happened to Banka Bioloo's margins in Q2 FY27?
See what Banka Bioloo Ltd said on profitability & margins — free account, 30 seconds.
What capex is Banka Bioloo planning?
- Megaliter Varunaa portfolio:
- 16 projects contracted, 13 commissioned by Q2 FY26-27, 3 work in progress
- Contracted treatment capacity at 11 MLD (million litres per day)
- Contracted long-term value (LTV) ₹140+ Cr, ~80% yet to be recognized
- FY26-27 H1 Megaliter capex: ₹1,243 L (consolidated), funded by ₹500 L outside equity + ₹411 L borrowings
- Q2 FY26-27 standalone: 5 Sewage Treatment Plants (STPs) completed, 4 commissioned, 4 under commissioning (EPC + Megaliter)
- 25+ STP sites all to be online and monitored by Q3 FY26-27
- Execution focus FY27: Commission → Bill → Collect → Sustainable PBT
2 more points from Banka Bioloo Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Construction
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Banka Bioloo raising money or cutting debt?
See what Banka Bioloo Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Banka Bioloo's order book?
- Order book details as of 30 September 2026: ₹83.4 Cr unexecuted order book (₹24.9 Cr Rail, ₹58.5 Cr Non-Rail).
- Q2 FY26-27 order booking: ₹16 Cr (100% from private clients).
- H1 FY26-27 order booking: ₹20.2 Cr (Q1 ₹4.2 Cr + Q2 ₹16 Cr).
- At 31 March 2026, order book was ₹107 Cr with ~₹70 Cr identified for next 12 months execution (estimate, not guaranteed revenue).
- Q1 unexecuted order book at 30 June 2026 was ₹81.8 Cr (Rail ₹32 Cr, Non-Rail ₹49.8 Cr).
2 more points from Banka Bioloo Ltd's call on order book
Create a free account to keep reading this call
Banka Bioloo Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q2 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹18 Cr, net profit ₹2 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →More Q2 FY27 results in Construction
- Larsen & Toubro Q2 FY27 resultsOrder Book ₹8,535 Cr
- Cemindia Project Q2 FY27 results
- Kalpataru Projects International Q2 FY27 resultsRevenue ₹6,213 Cr
- IRB Infrastructure Developers Q2 FY27 results
- NBCC (India) Ltd Q2 FY27 results
- Engineers India Q2 FY27 results
- Central Mine Pla Q2 FY27 resultsRevenue ₹593.31 Cr · PAT ₹194.84 Cr
- Ircon International Q2 FY27 results
Continue your research
What Banka Bioloo's management said in earlier quarters
Others in Construction this season
- Dilip Buildcon (Q2 FY27)
2,250 Cr (down 5.36% YoY from Rs. Key investor presentation takeaways from Dilip Buildcon Ltd's Q2 FY27 investor presentation — and how it ranks against sector
- SEPC (Q2 FY27)
664.49 lakhs (approximately -2.8%) . Key results statement takeaways from SEPC Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- Power Mech Projects (Q2 FY27)
1,452.38 crores, up from Rs. Key results statement takeaways from Power Mech Projects Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- Samay Project (Q2 FY27)
Year-on-year growth in revenue is approximately 22.4% ((2461.19 . Key results statement takeaways from Samay Project Services Ltd's Q2 FY27 results statement —
Potential multibaggers · Q2 FY27
Potential multibaggers in Construction
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Banka Bioloo Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Banka Bioloo Ltd Q2 FY27 results?
Q2 FY26-27 Standalone Total Income: ₹1,656 Lakhs, up 24.5% YoY from ₹1,330 Lakhs (Page 9, 4). Standalone BBL Q2 FY26-27:.
What is Banka Bioloo Ltd share price analysis?
Banka Bioloo Ltd currently shows a neutral. The stock trades at a P/E of 142.8 with a market cap of ₹91 Cr. Investors should review the full earnings analysis for detailed insights.
Is Banka Bioloo Ltd planning capital expenditure?
Megaliter Varunaa portfolio:.
Keep Banka Bioloo Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
